메뉴 건너뛰기




Volumn 11, Issue 3, 2007, Pages 406-413

Highly functionalised sulfur-based silica scavengers for the efficient removal of palladium species from active pharmaceutical ingredients

Author keywords

[No Author keywords available]

Indexed keywords


EID: 34548282263     PISSN: 10836160     EISSN: None     Source Type: Journal    
DOI: 10.1021/op7000172     Document Type: Article
Times cited : (75)

References (40)
  • 5
    • 39049110077 scopus 로고    scopus 로고
    • Wilson, J. R. H.; Sullivan, A. C.; Man, S. Substituted Organopolysiloxanes and Use Thereof. WO2006013060, 2006.
    • Wilson, J. R. H.; Sullivan, A. C.; Man, S. Substituted Organopolysiloxanes and Use Thereof. WO2006013060, 2006.
  • 12
    • 0002769275 scopus 로고    scopus 로고
    • 1st ed, Diederich, F, Stang, P. J, Eds, Wiley-VCH: New York
    • Sonogashira, K. In Metal-Catalyzed Cross-Coupling Reactions, 1st ed.; Diederich, F., Stang, P. J., Eds.; Wiley-VCH: New York, 1998; p 203;
    • (1998) Metal-Catalyzed Cross-Coupling Reactions , pp. 203
    • Sonogashira, K.1
  • 18
    • 39049172973 scopus 로고    scopus 로고
    • 1st ed, Diederich, F, Stang, P. J, Eds, Wiley-VCH: New York, Chapter 3;
    • Suzuki, A. In Metal-Catalyzed Cross-Coupling Reactions, 1st ed.; Diederich, F., Stang, P. J., Eds.; Wiley-VCH: New York, 1998; Chapter 3;
    • (1998) Metal-Catalyzed Cross-Coupling Reactions
    • Suzuki, A.1
  • 20
    • 0033438776 scopus 로고    scopus 로고
    • Examples include: Ennis, D.; McManus, J.; Wood-Kaczmar, W.; Richard-son, J.; Smith, G.; Carstairs, A. Org. Process Res. Dev. 1999, 3, 248;
    • Examples include: Ennis, D.; McManus, J.; Wood-Kaczmar, W.; Richard-son, J.; Smith, G.; Carstairs, A. Org. Process Res. Dev. 1999, 3, 248;
  • 24
    • 39049153307 scopus 로고    scopus 로고
    • De Gasparo, M.; Webb, R. L. WO0002543, 2000;
    • De Gasparo, M.; Webb, R. L. WO0002543, 2000;
  • 30
    • 0000633011 scopus 로고
    • Trost, B. M, Fleming, I, Eds, Pergamon: New York, Chapter 4.3;
    • Heck, R. F. In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I., Eds.; Pergamon: New York, 1991; Vol. 4, Chapter 4.3;
    • (1991) Comprehensive Organic Synthesis , vol.4
    • Heck, R.F.1
  • 31
    • 4644349037 scopus 로고    scopus 로고
    • 2nd ed, de Meijere, A, Diederich, F, Eds, Witey-VCH: New York, Chapter 5
    • Bräse, S.; de Meijere, A. In Metal-Catalyzed Cross-Coupling Reactions, 2nd ed.; de Meijere, A., Diederich, F., Eds.; Witey-VCH: New York, 2004; Chapter 5, page 217;
    • (2004) Metal-Catalyzed Cross-Coupling Reactions , pp. 217
    • Bräse, S.1    de Meijere, A.2
  • 34
    • 24144441333 scopus 로고    scopus 로고
    • 2nd ed, de Meijere, A, Diederich, F, Eds, Wiley-VCH: New York, Chapter 13
    • Jiang, L.; Buchwald, S. L. In Metal-Catalyzed Cross-Coupling Reactions, 2nd ed.; de Meijere, A., Diederich, F., Eds.; Wiley-VCH: New York, 2004; Chapter 13, page 699;
    • (2004) Metal-Catalyzed Cross-Coupling Reactions , pp. 699
    • Jiang, L.1    Buchwald, S.L.2
  • 40
    • 39049089911 scopus 로고    scopus 로고
    • See U.S. Food and Drug Administration (www.fda.gov) and European Agency for the Evaluation of Medicinal Products (www.emea.eu.int). At the time of this writing, for the palladium group of metals, the regulatory guidance indicates acceptable residue levels of <5 ppm for oral drug products and <0.5 ppm for parenteral drug products.
    • See U.S. Food and Drug Administration (www.fda.gov) and European Agency for the Evaluation of Medicinal Products (www.emea.eu.int). At the time of this writing, for the palladium group of metals, the regulatory guidance indicates acceptable residue levels of <5 ppm for oral drug products and <0.5 ppm for parenteral drug products.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.